(1 - 31 von 84
)
Evotec enters into research collaboration with CRTD to ...
www.firmenpresse.de
Dr Cord Dohrmann, Chief Scientific Officer of Evotec, commented: "We are very pleased to enter into this collaboration with CRTD in the field of retinal diseases, which constitutes a market of enormous unmet medical need. CRTD is a world leader in stem cell-derived modelling of retinal disease and thus fits perfectly into our strategy to continue to build and expand Evotec's unique …
Evotec AG: Evotec And Bristol-Myers Squibb Expand iPSC ...
www.finanznachrichten.de
Dr Cord Dohrmann, Chief Scientific Officer of Evotec, commented: "We are very pleased about this latest expansion of our iPSC-alliance with Bristol-Myers Squibb. Patient-derived disease models ...
Collaboration Evotec iPSC - Fraunhofer IME
www.ime.fraunhofer.de
Dr Cord Dohrmann, Chief Scientific Officer of Evotec, commented: “We are very pleased to have teamed up with Fraunhofer IME-SP. As a life sciences organization that operates at the interface of academic and industrial ambition and with a number of iPSC-based initiatives already in place, it is perfectly positioned to provide cutting-edge technologies and expertise to support Evotec’s own ...
Evotec and Galapagos enter into collaboration in the field ...
www.wallstreet-online.de
Dr. Cord Dohrmann, Chief Scientific Officer of Evotec, comments: "We are delighted to be working with Galapagos on this innovative project in an area of high unmet medical need. The team at ...
sortiert nach Relevanz / Datum